CUSIP 55083R203COM NEWLYELQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
67 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Arch Venture Management, LLC | 2.76M | $84.92M | 0 | Held |
| 2 | Gsk PLC | 1.51M | $46.56M | +1.51M | New Position |
| 3 | Mwg Caph Ltd | 1.01M | $31.03M | +1.01M | New Position |
| 4 | Vanguard Group Inc | 826.4K | $25.44M |
| +47.4K |
| Added |
| 5 | Foresite Capital Management IV, LLC | 800.4K | $24.64M | 0 | Held |
| 6 | Orland Properties Ltd | 754.7K | $23.23M | 0 | Held |
| 7 | Almitas Capital LLC | 577.8K | $17.78M | 0 | Held |
| 8 | Foresite Capital Management V, LLC | 477.1K | $14.68M | 0 | Held |
| 9 | Venbio Partners LLC | 337.7K | $10.39M | −135.8K | Reduced |
| 10 | Citadel Advisors LLC | 324.7K | $9.99M | −14.8K | Reduced |
See every fund holding Lyell Immunopharma Inc, with full quarter-over-quarter share changes.
Unlock all holders